Home > News > University of Canterbury commisions an IBM Blue Gene/L supercomputer
May 30th, 2007
University of Canterbury commisions an IBM Blue Gene/L supercomputer
The MacDiarmid Institute for Advanced Materials and Nanotechnology, Victoria University of Wellington and AUT University will be foundation partners in the Blue Gene project.
Blue Gene is optimised for bandwidth, scalability and the ability to handle large amounts of data. Its modular design allows for computing components - or "racks" - to be added as needed.
The Blue Gene installed at the University of Canterbury will have two racks and will be the most powerful system in New Zealand. It will rank among the Top 100 most powerful supercomputers in the world, based on projections for the TOP500 Supercomputers list to be published in June 2007.
SUNY Polytechnic Institute Invites the Public to Attend its Popular Statewide 'NANOvember' Series of Outreach and Educational Events October 23rd, 2014
First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014
Raytheon, UMass Lowell open on-campus research institute: Industry leader’s researchers to collaborate with faculty, students to move key technologies forward through first-of-its-kind partnership October 11th, 2014
SUNY Colleges of Nanoscale Science and Engineering and National Institute for Occupational Safety and Health Announce Expanded Partnership October 2nd, 2014
First Observation of Electronic Structure in Ag-Rh Alloy Nanoparticles Having Hydrogen Absorbing: Storage Property –Attempting to solve the mystery of why Ag-Rh alloy nanoparticles have a similar property to Pd– October 30th, 2014
Iranians Present Model to Predict Photocatalytic Process in Removal of Pollutants October 30th, 2014
Production of Biocompatible Polymers in Iran October 30th, 2014
Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine October 30th, 2014